Skip to main content

Advertisement

Log in

Posterior Reversible Encephalopathy Syndrome Associated with Hemorrhage

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinico-radiological entity characterized by headache, encephalopathy, visual disturbances, and seizures in association with reversible vasogenic edema on neuroimaging. Intracerebral hemorrhage associated with PRES (PRES-ICH) is generally considered an atypical finding.

Methods

Retrospective case series.

Results

Seven patients were identified with PRES-ICH, four males and three females. The presenting clinical symptoms included headache (2), encephalopathy (5), vision changes (2), seizures (2), and hemiparesis (1). The co-morbid conditions included acute renal dysfunction (3), solid organ transplantation (3), bone marrow transplant (1), use of calcineurin inhibitor agents (4), and pre-eclampsia (1). Neuroimaging revealed intraparenchymal hemorrhage in six patients and subarachnoid hemorrhage in one patient. Six of the seven patients with PRES-related ICH had underlying bleeding diathesis, including one patient who was anti-coagulated with a heparin drip. The mean platelet count was 82.1 × 103/μl (range, 4–232 × 103/μl), and the mean INR value was 2.18 (range, 0.9–6.7). Two patients died during the acute hospitalization. Among the five survivors, only two patients had good functional outcome (pre-defined as mRS ≤ 1).

Conclusion

In our series, the majority of patients with PRES-ICH (85%) had an underlying bleeding diathesis or coagulopathy. Although PRES is typically considered to have a favorable prognosis, the clinical outcome of PRES with associated ICH can be more variable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500. doi:10.1056/NEJM199602223340803.

    Article  PubMed  CAS  Google Scholar 

  2. Lee V, Widjicks E, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205–10. doi:10.1001/archneurol.2007.46.

    Article  PubMed  Google Scholar 

  3. McKinney A, Short J, Truwit C, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189:904–12. doi:10.2214/AJR.07.2024.

    Article  PubMed  Google Scholar 

  4. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28:1320–7. doi:10.3174/ajnr.A0549.

    Article  PubMed  CAS  Google Scholar 

  5. Schwartz R. Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist. 2002;8:22–34. doi:10.1097/00127893-200201000-00003.

    Article  PubMed  Google Scholar 

  6. Schwartz R, Jones K, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159:379–83.

    PubMed  CAS  Google Scholar 

  7. Morris B, Laningham F, Snadlund J, et al. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer. 2007;48:152–9. doi:10.1002/pbc.20703.

    Article  PubMed  Google Scholar 

  8. Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003;29:2323–6. doi:10.1007/s00134-003-1901-1.

    Article  PubMed  Google Scholar 

  9. Scwhartz R, Bravo S, Klufas R, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRI findings in 16 cases. AJR Am J Roentgenol. 1995;165(3):627–31.

    Google Scholar 

  10. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol. 1996;166:683–8.

    PubMed  CAS  Google Scholar 

  11. Truwit CL, Denarco CP, Lake JR, et al. MR imaging of reversible cyclosporine A-induced neurotoxicity. AJNR Am J Neuroradiol. 1991;12:651–9.

    PubMed  CAS  Google Scholar 

  12. Small SL, Fukui MB, Bramblett GT, et al. Immunsuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol. 1996;40:575–80. doi:10.1002/ana.410400406.

    Article  PubMed  CAS  Google Scholar 

  13. Tam CS, Galanos J, Seymour JF, et al. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol. 2004;77:72–6. doi:10.1002/ajh.20147.

    Article  PubMed  CAS  Google Scholar 

  14. Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2005;47:652–6. doi:10.1007/s00234-005-1399-z.

    Article  PubMed  CAS  Google Scholar 

  15. Lamy C, Oppenheim C, Meder JF, et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14:89–96. doi:10.1177/1051228403258161.

    Article  PubMed  CAS  Google Scholar 

  16. Schiff D, Lopes MB. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care. 2005;2:303–5. doi:10.1385/NCC:2:3:303.

    Article  PubMed  Google Scholar 

  17. Bartynski WS, Boardman JF. Catheter angiography, MR angiography and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;29:447–55. doi:10.3174/ajnr.A0839.

    Article  PubMed  Google Scholar 

  18. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective series of 67 patients. Brain. 2007;130:3091–101. doi:10.1093/brain/awm256.

    Article  PubMed  Google Scholar 

  19. Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006;16:170–5.

    Article  PubMed  Google Scholar 

  20. Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery. 1999;44:1113–6. doi:10.1097/00006123-199905000-00097.

    Article  PubMed  CAS  Google Scholar 

  21. Apollon KM, Robinson JN, Schwartz RB, Norwitz ER. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol. 2000;95:1017–9. doi:10.1016/S0029-7844(00)00878-4.

    Article  PubMed  CAS  Google Scholar 

  22. Bartysnki WS. Posterior reversible encephalopathy syndrome, Part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–9. doi:10.3174/ajnr.A0929.

    Article  Google Scholar 

  23. Winn R, Youman J, Zweinenberg-Lee M, Muizelaar JP. Clinical pathophysiology of traumatic brain injury. In: Youman’s Neurological Surgery, 5th edn. Philadelphia: Saunders; 2004. p. 5039–64.

  24. Bayliss W. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28:220–31.

    PubMed  CAS  Google Scholar 

  25. Horbinski C, Bartynski WS, Carson-Walter E, et al. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking and VEGF expression. Am J Neuroradiol. 2008; Epub ahead of print.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vivien H. Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aranas, R.M., Prabhakaran, S. & Lee, V.H. Posterior Reversible Encephalopathy Syndrome Associated with Hemorrhage. Neurocrit Care 10, 306–312 (2009). https://doi.org/10.1007/s12028-009-9200-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-009-9200-5

Keywords

Navigation